Literature DB >> 10548443

A unique drug treatment program for pregnant and postpartum substance-using women in New York City: results of a pilot project, 1990-1995.

C McMurtrie1, K D Rosenberg, B D Kerker, J Kan, E H Graham.   

Abstract

In the 1980s, there was virtually no drug treatment for pregnant women in New York City, especially women who used crack cocaine. The purpose of the Parent and Child Enrichment (PACE) demonstration project was to assess the effectiveness of the one-stop shopping model of drug treatment for this population. Among PACE clients, 88% were primarily users of crack cocaine. The mean total length of stay was 100.0 days (median 55.5 days). Client retention 42 days after intake was 54.3%. This paper describes the essential components of this program model. "Long-stay" and "short-stay" clients were compared using urine toxicology tests and activity logs. In addition, the birth outcomes of clients were compared to two similar populations. A strong positive correlation was found between total length of stay and low rate of positive urine drug tests (UDTs). Infants of PACE long-stay clients had greater mean birth weight, less low birth weight, and less intrauterine growth retardation than the infants of the comparison groups. Fetal exposure to cocaine was decreased dramatically among women who were enrolled for 42 or more days during their pregnancy. This model of drug treatment for pregnant and postpartum women seems to improve mothers' lives, fetal drug exposure, and birth outcome significantly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548443     DOI: 10.1081/ada-100101887

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  8 in total

Review 1.  The effects of maternal cocaine abuse on mothers and newborns.

Authors:  K Kaltenbach
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

3.  Incentives for retention of pregnant substance users: a secondary analysis.

Authors:  Gregory Brigham; Theresa Winhusen; Daniel Lewis; Frankie Kropp
Journal:  J Subst Abuse Treat       Date:  2009-07-03

4.  Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.

Authors:  Ana de Castro; Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-24       Impact factor: 3.205

5.  Family discord is associated with increased substance use for pregnant substance users.

Authors:  Wayne H Denton; Bryon H Adinoff; Daniel Lewis; Robrina Walker; Theresa Winhusen
Journal:  Subst Use Misuse       Date:  2013-10-09       Impact factor: 2.164

6.  Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry.

Authors:  Ana de Castro; Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-06       Impact factor: 3.367

7.  Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users.

Authors:  Theresa Winhusen; Frankie Kropp; Dean Babcock; Diane Hague; Sarah J Erickson; Connie Renz; Leela Rau; Daniel Lewis; Jeff Leimberger; Eugene Somoza
Journal:  J Subst Abuse Treat       Date:  2008-02-20

8.  Mono- versus polydrug abuse patterns among publicly funded clients.

Authors:  Satish Kedia; Marie A Sell; George Relyea
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-11-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.